What Do Analysts Think About UniQure (QURE)?

1 week ago 8

Noor Ul Ain Rehman

Sun, December 21, 2025 astatine 8:56 AM CST 2 min read

UniQure (NASDAQ:QURE) is 1 of the champion small headdress stocks to bargain with immense upside potential. Stifel slashed the terms people connected UniQure (NASDAQ:QURE) to $40 from $50 connected December 11, keeping a Buy standing connected the banal and stating that it “refreshed diligence” connected respective companies nether its sum successful the biotechnology sector. The steadfast added that it made respective estimate, model, and terms people changes for a 2026 look up enactment for the sector.

Is uniQure N.V. (QURE) the Most Promising Growth Stock According to Wall Street Analysts?

UniQure (NASDAQ:QURE) besides received a standing update from Mizuho expert Uy Ear connected December 8, who lowered the terms people to $33 from $60 portion keeping an Outperform standing connected the stock. The steadfast cited the lowering of its presumption of the company’s probability of occurrence and expected motorboat twelvemonth for AMT-130 by 1 year.

This followed UniQure’s (NASDAQ:QURE) announcement connected December 4 that it received the last gathering minutes from the FDA regarding the pre-Biologics License Application (BLA) gathering that was held connected October 29 to sermon the exertion for AMT-130. AMT-130 is an investigational cistron therapy for Huntington’s illness (HD).

Management reported that the FDA conveyed successful the last gathering minutes that the submitted information from the Phase I/II studies of AMT-130 was presently improbable to connection the superior grounds that could enactment a BLA submission. UniQure (NASDAQ:QURE) stated that it is evaluating the feedback carefully, and has plans to urgently petition a follow-up gathering with the FDA for fiscal Q1 2026.

UniQure (NASDAQ:QURE) discovers, develops, and commercializes innovative cistron therapies, with its discoveries focused connected treating Huntington’s disease, glybera, hemophilia, and cardiovascular problems.

While we admit the imaginable of QURE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.